Coronary artery bypass grafting in a patient with Gilbert syndrome

Abstract

Here in we present a case of a postoperative jaundice due to Gilbert's syndrome in a patient who was suffering from coronary artery disease and undergone coronary artery bypass grafting operation. Signs and symptoms of jaundice developed on the postoperative first day and resolved spontaneously after 7 days. The diagnosis and characteristics of Gilbert's syndrome and other related abnormalities and factors relevant to anesthesia and cardiopulmonary by-pass, which affect bilirubin metabolism, are discussed.

Keywords

• Coronary artery disease, coronary artery bypass grafting, Gilbert\'s syndrome

Gilbert sendromlu bir hastada coroner arter bypass greftlemesi

Öz

Biz bu çalışmamızda; koroner arter bypass greftleme operasyonu yaptığımız koroner arter hastasında, Gilbert sendromuna bağlı postoperatif sarılığı sunduk. Sarılık belirti ve bulguları post-operatif birinci günde başlayıp,post-operatif yedinci günde kendiliğinden kayboldu.Gilbert sendromunun tanısı,özellikleri ve ilişkili diğer anormallikler ile birlikte anestezi ve kardiyopulmoner bypass'ın bilirübin metabolizmasına etkileri tartışıldı.

Anahtar Kelimeler

• Koroner arter hastalığı, koroner arter bypass greftleme, Gilbert sendromu

Kaynakça

1. Strassburg CP. Hyperbilirubinemia syndromes (GilbertMeulengracht, Crigler-Najjar, Dubin-Johnson, and Rotor syndrome). Best Pract Res Clin Gastroenterol 2010;24(5):555-71.
2. Bosma PJ. Inherited disorder of bilirubin metabolism. J Hepatol 2003;38(1):107-17.
3. Foulk WT, Butt HR, Owen CA Jr, Whitcomb FF Jr,Mason HL. Constitutional hepatic dysfunction (Gilbert’s syndrome): its natural history and related syndromes. Medicine (Baltimore) 1959;38(1):25-46.
4. Vítek L, Jirsa M, Brodanová M, Kalab M, Marecek Z, Danzig V, Novotný L, Kotal P. Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels. Atherosclerosis 2002;160(2):449-56.
5. Schwertner HA, Jackson WG, Tolan G. (1994) Association of low serum concentration of bilirubin with increased risk of coronary artery disease. Clin Chem 1994;40(1):18-23.
6. Macklon AF, Savage RL, Rawlins MD. Gilbert’s syndrome and drug metabolism. Clin Pharmacokinet 1979;4(3):223-32.